Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Charles River Laboratories International Inc shares valued at $1,430,918 were sold by WALLMAN RICHARD F on Nov 07 ’24. At $216.12 per share, WALLMAN RICHARD F sold 6,621 shares. The insider’s holdings dropped to 12,386 shares worth approximately $2.33 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, WALLMAN RICHARD F sold 1,000 shares, netting a total of over 216,500 in proceeds. Following the sale of shares at $216.50 each, the insider now holds 0 shares.
Before that, WALLMAN RICHARD F had added 12,161 shares to its account. In a trade valued at $2,626,923, the Director bought Charles River Laboratories International Inc shares for $216.01 each.
As published in a research note from CLSA on November 18, 2024, Charles River Laboratories International Inc [CRL] has been rated down from a Hold to an Underperform and the price target has been revised to $164. Analysts at CLSA upgraded the stock from ‘”an Underperform”‘ to ‘”a Hold”‘ outlook in a report released in early November. As of October 23, 2024, CLSA has initiated its “an Underperform” rating for CRL. Earlier on October 14, 2024, Redburn Atlantic initiated its rating. Their recommendation was “a Sell” for CRL stock.
Analyzing CRL Stock Performance
During the last five days, there has been a drop of approximately -9.02%. Over the course of the year, Charles River Laboratories International Inc shares have dropped approximately -20.52%. Shares of the company reached a 52-week high of $275.00 on 03/08/24 and a 52-week low of $176.48 on 10/31/24. A 50-day SMA is recorded $195.05, while a 200-day SMA reached $219.25. Nevertheless, trading volume fell to 0.64 million shares from 0.71 million shares the previous day.
Support And Resistance Levels for Charles River Laboratories International Inc (CRL)
According to the 24-hour chart, there is a support level at 184.86, which, if violated, would cause prices to drop to 181.82. In the upper region, resistance lies at 189.63. The next price resistance is at 191.35. RSI (Relative Strength Index) is 44.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -11.50, which suggests the price will decrease in the coming days. Percent R is at 83.30%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
